603 related articles for article (PubMed ID: 18539959)
21. Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.
McCubrey JA; Abrams SL; Stadelman K; Chappell WH; Lahair M; Ferland RA; Steelman LS
Adv Enzyme Regul; 2010; 50(1):285-307. PubMed ID: 19895837
[No Abstract] [Full Text] [Related]
22. Wnt signaling, stem cells, and the cellular origin of breast cancer.
Lindvall C; Bu W; Williams BO; Li Y
Stem Cell Rev; 2007 Jun; 3(2):157-68. PubMed ID: 17873348
[TBL] [Abstract][Full Text] [Related]
23. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
[TBL] [Abstract][Full Text] [Related]
24. Cytokeratin 19
Saha SK; Kim K; Yang GM; Choi HY; Cho SG
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29747452
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer stem cells: current advances and clinical implications.
Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
[TBL] [Abstract][Full Text] [Related]
26. Targeting the perpetrator: breast cancer stem cell therapeutics.
Pal A; Valdez KE; Carletti MZ; Behbod F
Curr Drug Targets; 2010 Sep; 11(9):1147-56. PubMed ID: 20545606
[TBL] [Abstract][Full Text] [Related]
27. Mammary gland stem cells and their application in breast cancer.
Yang X; Wang H; Jiao B
Oncotarget; 2017 Feb; 8(6):10675-10691. PubMed ID: 27793013
[TBL] [Abstract][Full Text] [Related]
28. Developmental pathways in breast cancer and breast tumor-initiating cells: therapeutic implications.
Izrailit J; Reedijk M
Cancer Lett; 2012 Apr; 317(2):115-26. PubMed ID: 22123293
[TBL] [Abstract][Full Text] [Related]
29. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer stem cells: A review of their characteristics and the agents that affect them.
Shan NL; Shin Y; Yang G; Furmanski P; Suh N
Mol Carcinog; 2021 Feb; 60(2):73-100. PubMed ID: 33428807
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer stem cells: Biology and therapeutic implications.
Butti R; Gunasekaran VP; Kumar TVS; Banerjee P; Kundu GC
Int J Biochem Cell Biol; 2019 Feb; 107():38-52. PubMed ID: 30529656
[TBL] [Abstract][Full Text] [Related]
32. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.
Korkaya H; Paulson A; Iovino F; Wicha MS
Oncogene; 2008 Oct; 27(47):6120-30. PubMed ID: 18591932
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer stem cells-research opportunities utilizing mathematical modeling.
Ashkenazi R; Jackson TL; Dontu G; Wicha MS
Stem Cell Rev; 2007 Jun; 3(2):176-82. PubMed ID: 17873350
[TBL] [Abstract][Full Text] [Related]
34. Cancer stem cells: a novel paradigm for cancer prevention and treatment.
Subramaniam D; Ramalingam S; Houchen CW; Anant S
Mini Rev Med Chem; 2010 May; 10(5):359-71. PubMed ID: 20370703
[TBL] [Abstract][Full Text] [Related]
35. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
[TBL] [Abstract][Full Text] [Related]
36. Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways.
Abetov D; Mustapova Z; Saliev T; Bulanin D; Batyrbekov K; Gilman CP
Stem Cell Rev Rep; 2015 Dec; 11(6):909-18. PubMed ID: 26210995
[TBL] [Abstract][Full Text] [Related]
37. Drug discovery approaches to target Wnt signaling in cancer stem cells.
Curtin JC; Lorenzi MV
Oncotarget; 2010 Nov; 1(7):563-577. PubMed ID: 21317452
[TBL] [Abstract][Full Text] [Related]
38. Retinoic acid, CYP26, and drug resistance in the stem cell niche.
Alonso S; Jones RJ; Ghiaur G
Exp Hematol; 2017 Oct; 54():17-25. PubMed ID: 28754309
[TBL] [Abstract][Full Text] [Related]
39. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.
Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G
Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479
[TBL] [Abstract][Full Text] [Related]
40. COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis.
Majumder M; Xin X; Liu L; Tutunea-Fatan E; Rodriguez-Torres M; Vincent K; Postovit LM; Hess D; Lala PK
Stem Cells; 2016 Sep; 34(9):2290-305. PubMed ID: 27301070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
